SCHEMBL6742592

SCHEMBL6742592

[CH2]Cc1c(N)cccc1C#N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
TSHR P16473 4/20 0.39
MAP2K1 Q02750 1/20 0.36
KDM4E B2RXH2 5/20 0.33
HPGD P15428 4/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GAA P10253 2/20 0.33
HTT P42858 2/20 0.33
LMNA P02545 2/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
MPO P05164 1/20 0.32
ALDH1A1 P00352 3/20 0.31
HSD17B10 Q99714 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28190550 0.82 CYP3A4 (0.44) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL6737403 0.80 CYP3A4 (0.43) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL1375312 0.80 CYP3A4 (0.43) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL6457239 0.77 CYP3A4 (0.41) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL19437188 0.76 MPO (0.39) TSHRKDM4EHPGDMEN1MAPT
SCHEMBL6739582 0.76 TSHR (0.54) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL250206 0.76 CYP3A4 (0.40) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL29355884 0.76 CYP1A2 (0.40) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL6089703 0.74 CYP3A4 (0.42) CYP3A4CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL6740454 0.72 CYP3A4 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed